AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: CANF
Report Date: 2026-04-30
Full Report: https://amaly.io/stock/CANF

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: B
Description: Can-Fite BioPharma Ltd. (CANF) is a clinical-stage biotechnology company developing small molecule therapeutics for cancer, inflammatory diseases, and other conditions. Its core business activities are Shariah-compliant, focusing on health-promoting R&D. However, high interest income from cash reserves (30.12% of revenue) results in financial non-compliance across standards. The company is not included in major Shariah indices due to this impurity. Purification of 30.12% of dividends is required, and investors should monitor for improvements in financial management.

Primary Compliance Concerns:
- Interest Income Ratio: 30.12% (threshold: 5%)

Purification Requirement: 30.12%
Index Inclusion: Not included in any major Shariah indices

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 2.9%
Interest Income Ratio: 30.1%
Purification Required: 30.12%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2026-01-31

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q1 2026
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-04-02T12:00:00Z

---
Full interactive report: https://amaly.io/stock/CANF
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.